Skip to Content

Special Pharma Service
Amorphous Content Determination

Knowing the amorphous content of pharmaceutical materials is critical, as even small amounts can alter solubility, stability, and drug performance. Undetected amorphous fractions may lead to recrystallization, impacting shelf life, manufacturability, and regulatory compliance.

Our team at Particle Characterisation Laboratory (PCL) has extensive expertise in detecting and quantifying amorphous content by combining complementary materials characterization techniques. With our reports, drug developers have the clarity they need to design stable, effective formulations.

Support for Inhalation APIs

Quick, accurate, and effective measurement of amorphous content in a sample is vital to reliably expediting research and development. 

Through our extensive work in this space, PCL has developed and establish experimental methods for analysing a range of common APIs.

Don't see your API here? We are experts at working to our clients requirements in method development for new inhalation APIs .

Available API Methods:

  • Albuterol Sulphate / Salbutamol Sulphate
  • Budesonide
  • Formoterol Fumarate
  • Fluticasone Propionate
  • Indacaterol Acetate
  • Vilanterol Trifenate

Techniques for Amorphous Content Determination

Contact us now to discuss your research solution:

Call us:
+91 403 5176 902

WhatsApp us:
+91 900 3080 109

Get in touch now for quality scientific solutions 

Provide a few simple details on your scientific challenges, and we will provide a detailed, tailored scientific solution, and colaborate with you from start to finish so you have precise and reliable results.